Curaleaf (OTCMKTS:CURLF) Price Target Cut to C$24.00

Curaleaf (OTCMKTS:CURLF – Get Rating) had its price target reduced by investment analysts at Stifel Nicolaus from C$25.00 to C$24.00 in a research note issued to investors on Tuesday, The Fly reports.

A number of other research analysts have also recently issued reports on CURLF. MKM Partners reissued a “buy” rating and set a $14.00 price objective on shares of Curaleaf in a report on Tuesday. Cantor Fitzgerald boosted their price objective on Curaleaf from $15.50 to $16.50 and gave the stock an “overweight” rating in a report on Monday, April 25th. Benchmark started coverage on Curaleaf in a research report on Friday, February 25th. They set a “buy” rating and a $12.00 target price for the company. Finally, Needham & Company LLC decreased their price objective on Curaleaf from $17.00 to $15.00 and set a “buy” rating for the company in a research report on Friday, March 4th. Two research analysts have rated the stock with a hold rating and nine have issued a buy rating to the company. According to data from MarketBeat, the stock currently has a consensus rating of “Buy” and an average price target of $19.05.

CURLF traded down $0.34 during midday trading on Tuesday, hitting $5.61. 489,728 shares of the company’s stock traded hands, compared to its average volume of 660,853. The stock’s fifty day simple moving average is $6.37 and its 200-day simple moving average is $7.92. Curaleaf has a one year low of $5.14 and a one year high of $15.47.

Curaleaf (OTCMKTS:CURLF – Get Rating) last released its quarterly earnings results on Thursday, March 3rd. The company reported ($0.04) EPS for the quarter, missing analysts’ consensus estimates of ($0.02) by ($0.02).

Curaleaf Company Profile (Get Rating)

Curaleaf Holdings, Inc operates a cannabis operator in the United States. It operates in two segments, Cannabis Operations and Non-Cannabis Operations. The Cannabis Operations segment engages in the production and sale of cannabis through retail and wholesale channels. The Non-Cannabis Operations segment provides professional services, including cultivation, processing, and retail know-how and back-office administration, intellectual property licensing, real estate leasing services, and lending facilities to medical and adult-use cannabis licensees under management service agreements.

Further Reading